e.g. Tata motors, Reliance MF, 500570

Aarey Drugs & Pharmaceuticals Ltd. - Research Center

524412 AAREYDRUGS Group (T) BSE data
 
Back to Company Page
Statement:

Profit loss account

(Rs crore)
Mar ' 25 Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21
Income
Operating income 473.94 395.62 418.96 492.68 348.42
Expenses
Material consumed 462.06 381.90 403.84 472.06 337.79
Manufacturing expenses - - - - -
Personnel expenses 0.81 0.72 0.81 0.98 0.40
Selling expenses - - - - -
Adminstrative expenses 8.18 8.55 6.58 8.37 5.59
Expenses capitalised - - - - -
Cost of sales 471.04 391.17 411.23 481.41 343.78
Operating profit 2.90 4.45 7.72 11.27 4.64
Other recurring income 9.81 6.96 2.73 2.75 7.01
Adjusted PBDIT 12.71 11.42 10.45 14.02 11.65
Financial expenses 4.66 4.38 2.87 2.00 2.43
Depreciation 1.94 1.70 1.57 1.99 0.92
Other write offs - - - - -
Adjusted PBT 6.10 5.34 6.01 10.03 8.30
Tax charges 2.08 0.66 2.24 3.48 1.79
Adjusted PAT 4.02 4.68 3.77 6.54 6.51
Non recurring items - - - - -
Other non cash adjustments - - - - -
Reported net profit 4.02 4.68 3.77 6.54 6.51
Earnigs before appropriation 57.13 53.11 48.42 44.65 38.11
Equity dividend - - - - -
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings 57.13 53.11 48.42 44.65 38.11
Close
Add Aarey Drugs & Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Aarey Drugs & Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback